HomeVYNE • NASDAQ
add
Vyne Therapeutics Inc
Previous close
$2.29
Day range
$2.11 - $2.36
Year range
$1.67 - $6.79
Market cap
31.24M USD
Avg Volume
35.99K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 98.00K | -1.01% |
Operating expense | 7.48M | 25.18% |
Net income | -6.25M | -11.15% |
Net profit margin | -6.38K | -12.29% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 85.95M | 184.48% |
Total assets | 91.68M | 159.98% |
Total liabilities | 8.31M | -5.96% |
Total equity | 83.37M | — |
Shares outstanding | 14.53M | — |
Price to book | 0.39 | — |
Return on assets | -19.49% | — |
Return on capital | -21.39% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -6.25M | -11.15% |
Cash from operations | -7.98M | -45.71% |
Cash from investing | -3.57M | -171.38% |
Cash from financing | -4.00K | 98.16% |
Net change in cash | -11.56M | -1,562.59% |
Free cash flow | -5.80M | -6,815.65% |
About
Founded
2003
Headquarters
Website
Employees
10